Results 11 to 20 of about 309 (58)

Atrial Fibrillation in Cancer Patients: Who is at Risk? [PDF]

open access: yes, 2022
Cancer is the second leading cause of mortality in the world, second only to cardiovascular diseases. Simultaneously cancer mortality has been steadily decreasing due to the development  of new chemotherapy and targeted  drugs  and the improvement  of ...
D. A. Vyzhigin   +4 more
core   +2 more sources

Характеристика морфофункциональных параметров сердца и биомаркеров повреждения миокарда у пациентов различных возрастных групп на фоне терапии антрациклиновыми антибиотиками [PDF]

open access: yes, 2021
Оценка изменений внутрисердечной гемодинамики, а также уровней тропонина I и NT-proBNP при достижении средних кумулятивных доз антрациклинов (250 мг/м2 по доксорубицину) у пациентов различных возрастных ...
Ватутин, Н. Т.   +1 more
core   +1 more source

Cardioprotective Strategies for Doxorubicin-induced Cardiotoxicity: Present and Future [PDF]

open access: yes, 2022
The improvement of drugs and protocols of chemotherapeutic treatment has led to improved outcomes and survival in patients with cancer. But along with this, at first glance a positive point, there was another interdisciplinary problem, which is the need ...
A. M. Chaulin, D. V. Duplyakov
core   +2 more sources

Нарушения ритма сердца у больных с онкологическими заболеваниями

open access: yesUniversity Therapeutic Journal, 2021
Онкологические заболевания - одна из ведущих причин смертности и инвалидизации населения. Прогресс лекарственной и лучевой терапии значительно увеличил продолжительность жизни онкологических больных благодаря передовой диагностике и инновационным схемам
Ульяна Александровна Григорьева
doaj  

What are the indications for combined use of hydroxychloroquine and lopinavir/ritonavir, and how should treatment safety monitoring be performed?

open access: yesКачественная клиническая практика, 2020
Some guidelines describe combined use of hydroxychloroquine and lopinavir/ritonavir as one of the treatment alternatives for severe COVID-19, yet this treatment is not preferable.
Yu. Yu. Kiselev   +3 more
doaj   +1 more source

Clinical Manifestations of Cardiotoxicity in Acute Leukemia and Methods for their Examination [PDF]

open access: yes, 2023
Currently, more and more attention is paid to cardiotoxicity, which develops against the background of anticancer treatment. Achievements of modern oncology are associated with the use of effective combinations of chemotherapeutic drugs and radiation ...
Abdukhalimovna, Amerova Dilafruz   +2 more
core   +2 more sources

MODERN APPROACHES TO DETECTING EARLY SUBCLINICAL CARDIOTOXICITY INDUCED BY CHEMOTHERAPY IN PATIENTS WITH BREAST CANCER [PDF]

open access: yes, 2018
In recent decades, developed countries of the world have made progress in the treatment of breast cancer, both because of the early detection of cancer and the use of modern methods of treatment (target therapy and chemotherapy, radiation therapy and ...
A. A. Avalyan   +3 more
core   +2 more sources

ОСОБЕННОСТИ ЛУЧЕВОЙ ТОКСИЧНОСТИ ПРИ ПРОВЕДЕНИИ ЛУЧЕВОЙ ТЕРАПИИ С ТРАСТУЗУМАБОМ [PDF]

open access: yes, 2021
The aim of the study was to determine and analyze the most significant risk factors for developing cardiac, pulmonary and skin toxicities among patients who received concurrent radiation therapy and chemotherapy with trastuzumab.Material and methods. The
A. Lozhkov A.   +13 more
core   +2 more sources

CARDIOTOXICITY ANTIPSYCHOTICS: MORPHO-ELECTROCARDIOGRAPHIC ASSOCIATIONS

open access: yesРациональная фармакотерапия в кардиологии, 2015
Aim. To study the morphological and functional heart disorders in patients with different duration of antipsychotic treatment. Material and methods. Medical documents of 78 deceased schizophrenic patients treated with antipsychotic drugs were studied ...
V. P. Volkov
doaj   +1 more source

Кардиоваскулярная токсичность, индуцированная применением противоопухолевых препаратов, и современные методы лечения опухолевых новообразований [PDF]

open access: yes, 2020
Currently the oncological mortality takes the second place globally, the leading cause being cardiovascular diseases. The statistics of malignant neoplasms is rather negative all over the world.
G. M. Sakhautdinova   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy